












Title: Emergent properties of neural repair: elemental biology to therapeutic concepts 
 
Running Head: Emergent properties of neural repair 
 
Corresponding author’s contact information: 
S. Thomas Carmichael, M.D., Ph.D. 
Professor and Vice Chair for Research and Programs 
Department of Neurology 
David Geffen School of Medicine at UCLA 








Number of characters in the title and running head: Title 11 words, Running Head 5 words 
Number of words in the abstract, Introduction, Discussion and the body of the manuscript (not 
including abstract or references, figure legends, etc.) 
 Abstract 250 
 Introduction/Discussion: not relevant to this review article 
 Body of Manuscript: 4130 
Number of figures, color figures, and tables: 1 color figure 
  
Page 1 of 19 Annals of Neurology
This is the author manuscript accepted for publication and has undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to differences
between this version and the Version record. Please cite this article as doi:10.1002/ana.24653.











Stroke is the leading cause of adult disability. The last decade has seen advances in basic 
science research of neural repair in stroke. The brain forms new connections after stroke, which 
have a causal role in recovery of function. Brain progenitors, including neuronal and glia 
progenitors, respond to stroke and initiate a partial formation of new neurons and glial cells. The 
molecular systems that underlie axonal sprouting, neurogenesis and gliogenesis after stroke 
have recently been identified. Importantly, tractable drug targets exist within these molecular 
systems that might stimulate tissue repair. These basic science advances have taken the field 
to its first scientific milestone: the elemental principles of neural repair in stroke have been 
identified. The next stages in this field involve understanding how these elemental principles of 
recovery interact in the dynamic cellular systems of the repairing brain. Emergent principles 
arise out of the interaction of the fundamental or elemental principles in a system. In neural 
repair, the elemental principles of brain reorganization after stroke interact to generate higher 
order and distinct concepts of regenerative brain niches in cellular repair, neuronal networks in 
synaptic plasticity, and the distinction of molecular systems of neuroregeneration. Many of these 
emergent principles directly guide the development of new therapies, such as the necessity for 
spatial and temporal control in neural repair therapy delivery and the overlap of cancer and 
neural repair mechanisms. This review discusses the emergent principles of neural repair in 
stroke as they relate to scientific and therapeutic concepts in this field.  
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Emergent properties arise out of more fundamental properties in a given context and are distinct 
or irreducible. As individual fish form a school, the synchronous and coordinated movements of 
the group are distinct from the properties of the single fish1. A walk on a leafy street in the 
summertime Midwest brings the sound of the cicada. As cicadas sing in a group, the song takes 
on oscillating waves that emerge as properties with unique harmonics and function, distinct from 
the screech of the single male2. In these cases the properties of the group do not directly relate 
to properties of the single member, but emerge as elements uniquely related to the single 
members when they aggregate. 
 
Closer to home, synaptic plasticity is an emergent property of the molecular connections and 
transmitter release in a single synapse, which reflects the activity patterns of that synapse 
together with its interactions from adjacent synapses3. The migration of groups of cells in a three 
dimensional environment takes on properties that are not present in isolated cell migration. 
Migrating cells signal through group interactions that relay distant cues across the whole 
population4, something metaphorically similar to the school of fish. 
 
Tissue reorganization and repair after stroke shows emergent properties that stem from 
interactions of individual elements in reorganizing brain tissue. The basic or elemental 
properties of neural repair include axonal sprouting, neurogenesis, gliogenesis, and changes in 
neuronal excitability in peri-infarct tissue. Each of these cellular events is a distinct and 
definable property of the brain tissue response to stroke, and has irreducible elements in its 
response. For example, reactive astrocytes downregulate the uptake of the inhibitory transmitter 
GABA, and this causes an elevation in tonic GABA signaling and hypo-excitability of pyramidal 
neurons adjacent to stroke5. In post-stroke neurogenesis, angiogenic vessels release 
chemokines and growth factors that simulate immature neurons to migrate to areas of brain 
injury adjacent to the stroke core6-8. These individual neural repair events interact in the 
aggregate and evolve over time to produce properties that are different, larger and more 
important than then the properties of the single reactive astrocyte or migrating neuroblast. In a 
definitional sense, the formation of new neurons6-8, new oligodendrocytes9,10 or new 
connections11-13 has been interchangeably described as “repair” or “regeneration”. Both terms 
connote a process of renewal and growth of tissues after injury, and are literally true in a limited 
fashion in the CNS after injury12. This review will discuss emergent properties of neural repair 
from the epidemiology of stroke to the synapse, highlighting areas of clinical translation 
opportunity. These emergent properties are: Stroke is a Not a Killer but a Chronic and 
Progressive Disabling Disease, Behavioral Activity Shapes Tissue Regeneration, Molecular 
Memory Systems in Stroke Recovery (The Suffered is the Learned), Plasticity is a Risk for 
Neuroprotection, The Brain forms Regenerative Cellular Niches during Repair and Recovery, 
Engaging CNS Tissue Regeneration is like Activating a Cancer, Neural Repair Therapies 
Require Directed Effect, and Regeneration Does not Recapitulate Development. 
 
Stroke is a Not a Killer but a Chronic and Progressive Disabling Disease 
Stroke mortality is declining. Two years ago stroke slipped from the third leading cause of death 
to the fourth14 and this year it fell to the fifth leading cause of death15. This decline in mortality is 
welcomed and stems from implementation of stroke guidelines and improved care in the acute 
setting. Recent epidemiological studies indicate a decline in stroke incidence16. However, even 
with this decline in stroke incidence, mortality is declining faster than the reduction in 
incidence16. The prevalence of stroke is thus increasing. An emergent property of stroke 
epidemiology is that stroke is ever more a chronically disabling disease: stroke victims survive 
their stroke but not their disability. This stroke disability is substantial. Up to 80% of stroke 
patients may ultimately recover the ability to walk short distances, but most do not achieve the 
ability for community ambulation17. Initially, 70% to 80% of people who sustain a stroke have 
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upper-extremity impairment18,19. As with gait, most of these patients will recover but many do not 
regain functional use of the paretic arm In terms of personal function, 6 months after stroke a 
substantial proportion (25%−53%) of people remain dependent in at least one ADL task20,21. 
 
What makes matters worse is that stroke is not just disabling as reflected in these statistics, but 
stroke victims themselves show declines over time after their initial gains from 
neurorehabilitation22-25. Most of this decline may be due to inactivity and lack of task-specific 
practice26. This means that stroke disability progresses. The decline of stroke patients in initially 
recovered neurological function over time after stroke, through dis-use or non-use of the 
affected function, is a major target of outpatient neurorehabilitative therapies, such as 
occupational, physical and speech therapy, but to only a limited success. Overall in the 
epidemiology of stroke, the elemental facts of declining mortality, increasing prevalence and 
progressing disability mean that the emergent epidemiology of stroke is that it is now a 
chronically disabling and progressive disease. With no medical therapies that address 
neurological recovery after stroke, developing treatments for this chronically disabling and 
progressive disease becomes a research priority. 
 
Behavioral Activity Shapes Tissue Regeneration 
Stroke alters behavioral activity by directly changing neurological function, such as producing a 
hemiparesis, incoordination or aphasia. Clinicians in turn alter behavioral activity after stroke 
through neurorehabilitation, in which patients are placed in regimens of repetitive and task-
specific overuse of their affected function. The behavioral and neuronal activity of the brain 
regions that undergo repair alter the cellular events that are occurring during tissue repair of 
these brain regions.  An emergent property in stroke neural repair is that behavioral activity 
interacts with elements of cellular repair after stroke to create properties that are unique, and 
unexpected. 
 
An elemental process of repair is that axonal sprouting and the formation of new connections 
after stroke occurs in brain regions that are damaged or partially de-afferented from the stroke. 
Stroke triggers new connections to form in motor, somatosensory and premotor cortex adjacent 
to the stroke site, and in projections from cortex contralateral to the stroke site into distant 
connections in the striatum, midbrain and spinal cord11-13,27-32. In both contralateral cortex to the 
stroke, and ipsilateral or peri-infarct cortex, animal models indicate that axonal sprouting 
establishes new patterns of connections that are causally linked to recovery. In peri-infarct 
cortex, when new connections are stimulated from motor to premotor cortex motor recovery is 
enhanced, and when these same connections are blocked from forming motor recovery is 
reduced13,33. In contralateral cortex, when new connections form in the cervical spinal cord, 
reaching into the portion of the cervical spinal cord that has lost its original projection from the 
stroke site, this process mediates part of the motor recovery in a rat stroke model29. It appears 
that axonal sprouting is a widespread process after stroke, and that axonal sprouting in different 
functional areas can control recovery in distinct neuronal systems, such as corticospinal or 
premotor connections. These studies come from several distinct models of stroke in rats, mice 
and primates. Axonal sprouting cannot be definitively identified yet in human imaging studies, 
but the most extensive cortical re-mapping after stroke occurs in the same functional systems 
and relative areas of peri-infarct cortex that undergo axonal sprouting in primates, rats and 
mice12. Also, the paradigmatic axonal sprouting marker, GAP43, was first studied in its 
association with human stroke, where is induced in peri-infarct tissue34.  
 
Behavioral activity is also highly likely to modulate the structure of axonal fiber tracts after stroke 
in addition to the distal axonal connections of these fiber tracts in the spinal cord or peri-infarct 
cortex. Human studies show that the structure of specific white matter tracts are associated with 
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functional recovery after stroke, and can respond to behavioral activity37,38. The relationship of 
white matter tract structure and axonal sprouting has not been determined. Human studies 
image large white matter tracts and, through the diffusion of water, their myelination state and 
their directional organization37,39. Rodent studies image truly small axonal collaterals and fine 
synaptic terminations within the cervical spinal cord27-31. One set of studies is looking at the 
cross-country electrical power transmission lines and the other is looking at the electrical wiring 
of the end-user’s house. It is quite possible that a rehabilitation therapy may affect white matter 
structure and myelination, and not affect axonal terminal fields; or that axonal terminal fields 
may be affected and not gross structure of the myelin tract; or that both are affected by the 
same behavioral therapy after stroke. Because both myelinated fiber tracts and axonal terminal 
fields are sensitive to behavioral modulation29,38,40, both are likely altered to some degree after 
stroke and through neurorehabilitative therapies. But at present, the role of behavioral activity in 
modulating white matter structure after stroke has not been determined in animal models and 
only larger white matter tracts can be studied in humans41. 
 
The process of post-stroke axonal sprouting has basic cellular and molecular properties. Axonal 
connections are confined by the expression of glial growth inhibitory molecules, such as NogoA, 
EphrinA5 and chondroitin sulfate proteoglycans11,12 ,27-33. Opposed to these glial growth 
inhibitors, sprouting neurons activate a unique regenerative molecular program11-13. Outside of 
stroke, behavioral activity in the normal adult brain, such as overuse or learning in a forelimb 
task, induces local changes in synaptic connections on a small scale within the corresponding 
motor cortex33,35,36. However, when the behavioral activity patterns of neurorehabilitative therapy 
are added to the axonal sprouting response in stroke, emergent properties appear that are not 
present in each of these two parent conditions.  
 
One example of the interaction of behavioral brain activity and axonal sprouting is seen in peri-
infarct cortex after stroke. Stroke induces axonal sprouting in motor, somatosensory and 
premotor areas in peri-infarct cortex. When glial growth inhibitors are blocked after stroke, this 
axonal sprouting response is locally enhanced in these cortical areas11,33. When glial growth 
inhibitors are blocked and the animal is forced to overuse the affected forelimb, a model for the 
clinical approach of constraint-induced motor therapy, there is a magnitude of axonal sprouting 
that is remarkable in the adult brain. New projections are formed from motor cortex to 
widespread areas in prefrontal, orbitofrontal, temporal and parietal cortical areas in a substantial 
re-mapping of mapping of the ipsilateral hemisphere33. The magnitude and pattern of axonal 
sprouting that is seen when behavioral activity is modified under conditions of manipulation of 
glial growth inhibitors emerges as unique, widespread and unpredictable from the two individual 
conditions which underlie this response: behavioral activity alone and glial growth inhibition 
blockade alone35. This emergent property suggests that neurorehabilitative therapy will have 
great power to shape neuronal connections when these connections are released from the 
normal inhibition of the post-stroke brain (Figure). 
 
Other types of post-stroke axonal sprouting are also responsive to behavioral activity patterns. 
Axonal sprouting from the cortex contralateral to large strokes occurs in the projection from 
sensorimotor regions to the cervical spinal cord. This axonal sprouting response is into the 
portion of the cervical spinal cord that lost its corticospinal projection from the stroke site12,27. 
Blocking the myelin growth inhibitory protein NogoA or stimulating axonal sprouting with inosine 
enhances this axonal sprouting response27-31. Stimulating behavioral activity after stroke, such 
as with an enriched environment or repetitive forelimb tasks, also stimulates axonal sprouting 
from the cortex contralateral to the stroke into this denervated spinal cord28,31,32. When 
increased behavioral activity and blockade of Nogo signaling are combined, there is a significant 
increase in spinal cord axonal sprouting in stroke. However, if the behavioral activity increase 
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occurs at the time of the Nogo blockade, the axonal sprouting is exuberant and aberrant in the 
spinal cord and overall functional recovery is actually degraded—worse than in stroke alone. If 
Nogo blockade is induced first, followed by the rehabilitative activity, axonal sprouting is more 
targeted in the spinal cord and behavioral recovery is enhanced29. These findings, like those 
noted above in peri-infarct cortex, indicate that the combination of altered behavioral activity and 
blockade of growth inhibitors produces emergent properties that are not expected from the 
effects of either activity or growth-inhibitory interventions alone. 
 
 
The Suffered is the Learned 
The process of spontaneous recovery after stroke shares similarities with the process of normal 
motor learning. Both involve similar neuropsychological characteristics, such as learned non-
use, mass action, contextual interference and distributed practice42. Both occur with similar 
brain imaging changes in which an initially diffuse network of brain areas is funneled down with 
learning, training or recovery into a core set of brain areas directly involved in the task. On a 
cellular level, processes of memory formation and network changes in the post-stroke brain are 
both associated with LTP-like phenomena and dendritic spine morphogenesis. On a molecular 
level, learning and memory paradigms, such as in the hippocampus, are associated with 
expression changes in stathmin, RB3, GAP43 and the Nogo signaling system, and these same 
molecular pathways are involved in recovery from stroke12,43. An emergent property in neural 
repair after stroke is that molecular systems which mediate the synaptic plasticity that underlies 
learning and memory are co-opted in brain injury to produce recovery of function.  
 
There has been recent experimental testing of this idea. Two signaling processes that impact 
the synaptic signaling in learning and memory have been implicated in recovery after stroke. 
Tonic GABA receptors respond to extrasynaptic or ambient levels of GABA, are more sensitive 
than phasic (synaptic) GABAa receptors and desensitize more slowly. These inhibitory 
receptors can thus mediate an inhibitory chloride current that controls the baseline firing 
threshold of pyramidal neurons44. Tonic or extrasynaptic GABA signaling is a target in the 
learning and memory field, as blocking this current promotes neuronal excitability in the 
hippocampus and enhances learning and memory in many animal models44-46. In stroke, tonic 
GABA signaling is increased in peri-infarct cortex in a zone of cortex near the stroke site 
(0.2mm adjacent to the stroke) and produces a hypoexcitable state in pyramidal neurons in 
brain regions that normally mediate recovery of function.  This can be pharmacologically 
reversed to enhance recovery in several rodent models of stroke at a considerable delay after 
the infarct5,47. 
 
The finding of increased tonic inhibition or effectiveness of agents that block tonic GABA 
inhibition in promoting behavioral recovery has been reported in two models of cortical stroke in 
two species (rat and mouse) by independent investigators5,47. This replication meets part of the 
goals of stroke drug development guidelines (STAIR and STEPS criteria48,49) and is fairly 
rigorous in this field in terms of support. There remain additional studies that might enhance 
these findings, such as testing in other stroke models. Clinically, the literature on tonic GABA 
inhibition in humans after stroke is not strong because of the inability to measure tonic vs. 
phasic GABA signaling in clinically available techniques. No technique in human studies (TMS, 
tDC, MRI PET) can specifically measure tonic and not phasic inhibition50. Perhaps the closest 
ability to replicate the findings behind the mechanism of increased tonic GABA inhibition in a 
human study would be in measuring total extrasynaptic GABA levels, which in the mouse to be 
elevated because of reduced astrocyte uptake of GABA after stroke5. However, the only ability 
to measure GABA in humans is with [18]F-Flumazenil (which measures synaptic GABA receptor 
binding occupancy) and GABA MRS MRI (which measures total GABA levels in a 2 x 2 mm 
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block of brain tissue). Neither of these approaches is sensitive to phasic (synaptic) vs. tonic 
(extrasynaptic) GABA levels or activity50,51. Nonetheless, there are reports that good functional 
recovery is correlated with declining GABA levels after stroke52,53 and that motor learning is 
associated with a reduced GABA level in motor cortex54.  
 
These human and rodent findings on levels of inhibition after stroke imply generally that 
manipulation of cortical excitability may modulate recovery. Transcranial direct current 
stimulation (tDC) and theta burst magnetic stimulation (TMS) are methods to do this in humans. 
Unlike the pharmacological manipulation of tonic GABA in rodent models of stroke, which 
specifically manipulate excitatory neurons and preferentially those that have been impacted by 
stroke5, tDC and TMS more grossly affect all of the brain tissue in the electrical or magnetic 
field, and induce many distinct types of cortical circuits55. Nonetheless, small scale studies 
indicate that excitatory tDC or TMS over the ipsilesional hemisphere in stroke, or inhibitory tDC  
over the contralateral hemisphere, may improve recovery after stroke55. Larger scale trials are 
under way for this application56,57.  
 
Synaptic activity mediated by the AMPA subtype of the glutamate receptor is also a key process 
in memory formation. Manipulations that enhance AMPA receptor signaling increase long term 
potentiation and produce increased performance in many models of learning and memory58. 
Positive allosteric modulators of the AMPA receptor, which enhance AMPA receptor signaling 
only when glutamate is bound to the receptor, were originally developed as memory enhancing 
drugs59. Termed AMPAkines, these drugs stimulate learning and memory in normal conditions 
and disease models59,60. In stroke, AMPAkines also promote recovery of function. Specifically, 
high impact AMPAkines, which induce downstream production of BDNF, promote motor 
recovery. This action is via BDNF production, rather than through the increased excitability of 
AMPA receptor ion channel opening duration or amplitude. The action of AMPAkines after 
stroke occurs specifically in peri-infarct cortex, further indicating that stroke specifically alters 
neuronal networks in regions of recovery in a way that parallels learning and memory function61. 
The circuit-specific and regional effect (peri-infarct cortex) in modulating AMPA receptor 
signaling after stroke with pharmacological means contrasts with the more generalized action of 
tDC and TMS in inducing excitatory circuits in the brain.  
 
These data in tonic GABA and AMPA receptor signaling are supported by other studies in which 
molecular processes that affect molecular systems first described in learning and memory 
contexts also improve recovery after stroke61. The ancient Greeks used the term “ta pathemeta 
mathmeta”, the suffered is the learned. An emergent property in neural repair after stroke is that 
the damage suffered from the infarct sets in place mechanisms of learning that can be 
manipulated to promote recovery.  
 
 
Plasticity is a Risk for Neuroprotection: timing for a neural repair therapy 
The neuronal excitability in learning and memory systems after stroke that leads to enhanced 
recovery, and the increased behavioral activity in stroke rehabilitation that leads to enhanced 
recovery, also define a key emergent concept: mechanisms that enhance neuronal plasticity 
also de-stabilize a brain’s ability to deal with stress. Put more simply, enhancing neuroplasticity 
at times in which the acute insult of the stroke is still present will make the stroke worse. In 
studies with blocking tonic GABA signaling or enhancing signaling through the AMPA glutamate 
receptor, when therapy was within three to five days from the stroke, GABA antagonists or 
AMPA drugs make the stroke worse by increasing infarct size. When these therapies were 
initiated after this three to five day period, they do not change infarct size and enhance motor 
recovery5,60. Many neural repair therapies enhance endogenous neuronal plasticity in ways that 
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activate neuronal excitability, such as with enhancing signaling of the transcription factor Creb61 
and might be expected to also follow this timeline. This general principle of a trade-off between 
enhancing the plasticity of a cell vs. ensuring its ability to withstand stress is seen in other 
neuronal systems. Manipulations of the growth cone protein GAP43 enhance the ability of a 
neuron to grow a new axon after injury but also increase the level of cell death from that very 
same injury62,63. Neuronal cell types with the greatest resistance to cell death after injury usually 
also have the lowest regenerative capacity, such as Purkinje cells; whereas neuronal cell types 
with the greatest regenerative capacity after injury also suffer the most cell death when injured, 
such as inferior olivary neurons64. In neuronal sites as diverse as the optic nerve, dorsal root 
ganglion and cortex, lesions closest to the cell body provoke the greatest amount of cell death, 
but also induce a greater regenerative response—compared to lesions distant from the cell 
body in which there is little cell death and also little regeneration64-66. Outside of these 
experimental lesion and molecular observations, increasing the activity of the motor system 
early after stroke may exacerbate the stroke insult itself in animal models even though this 
same activity will lead to improved recovery at a later period after stroke65. 
 
Based on this transition from stroke damage to stroke repair, the timing of an activity or plasticity 
therapy in human stroke, based on animal model data, is not exactly clear. The early events of 
inflammatory cell infiltration and astrocytosis appear to follow similar time courses in rodent and 
human. The recovery curve for rodents also has a similar shape and ceiling to that of humans, 
except constricted to the first month after stroke in rodents and to the first three months after 
stroke in humans68,69. In humans, early and increased neurorehabilitative therapy after stroke 
may also worsen outcome compared to similar neurorehabilitative therapies introduced later70. 
The early time period in this VECTORS trial was 9 days after stroke70. Thus, it may be inferred 
that starting a neuroplasticity therapy earlier than the first week after stroke in humans positions 
this therapy within a window of risk for exacerbation of the initial stroke damage. 
 
The opposite applies in this emergent principle as well: treatments that protect the brain in 
stroke may worsen behavioral performance if given during the recovery phase60. Glutamate 
receptor antagonists and GABA receptor agonists reduce neuronal excitability and stroke size 
when given early after stroke, but degrade behavioral performance and recovery when given 
later after stroke60,71. The upshot of this emergent concept in stroke neural repair is that 
treatments that promote plasticity and recovery must clearly be distinguished from treatments 
that promote stability and protection, and a timeline developed in which each has its own 
window. 
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The Brain forms Regenerative Cellular Niches during Repair and Recovery 
Stroke triggers regenerative responses in neural stem cells and glial progenitors that mediate 
some aspects of repair. The term “regeneration” is far-reaching in its implication but literally true 
in its application to the limited processes of neurogenesis6-8,, oligodendrocyte generation9,10 and 
formation of new connections after stroke12 in that these processes form new circuits and cells 
in the brain after destructive injury. In post stroke neurogenesis, the multipotent neural stem 
cells and transit amplifying cells in the subventricular zone respond to stroke and proliferate. 
Immature neurons produced from these progenitor cells migrate to areas of injury and can 
differentiate into mature neurons with local synaptic connections and long distance projections6-
8. Ablation of newly derived immature neurons after stroke causes reduced recovery72. 
Immature neurons localize to angiogenic blood vessels in damaged tissue and are stimulated to 
migrate by growth factors or cytokines released by these vessels6-8. However, despite a robust 
initial neurogenic response, most of these immature neurons die. Post-stroke neurogenesis has 
been reported in human stroke, by utilizing tissue staining for protein markers of immature 
neurons in autopsy material73-75. However, a lack of post-stroke neurogenesis has been 
reported in human cortical stroke, using 14C labeling of newly born cells76. Both techniques have 
limitations in specificity and sensitivity, and may also miss a transient neurogenic response after 
stroke that is limited in size and then stopped77,78. Because of the nature of human studies, a 
definitive finding of clinical post-stroke neurogenesis remains lacking. 
 
Stroke also stimulates oligodendrocyte progenitor cells (OPCs) to divide and partially 
differentiate adjacent to the lesion9,10, a form of post-stroke gliogenesis. This has also been 
reported in human stroke79. Further white matter remodeling occurs in humans with stroke and 
with therapies that promote recovery in human stroke80,81. OPCs carry the capacity to 
differentiate into mature oligodendrocytes and are in a position to mediate neural repair, as 
occurs in the initial stages of multiple sclerosis. However, glial progenitor cells after stroke do 
not appear to differentiate into oligodendrocytes as in multiple sclerosis and the damage 
produced to myelinated fiber tracts is even worse in aged animals after white matter stroke82. 
This age effect on OPC and white matter responses appears to be mediated by greater local 
inflammation in the aged brain82 and by intrinsic differences in aged OPCs83. In another aspect 
of gliogenesis, stroke induces proliferation of astrocytes adjacent to the lesion84,85, and a 
remarkable generation of new astrocytes from neural progenitor cells that migrate from the 
subventricular zone86,87. Astrocytes proliferate near human stroke88 but the role of this 
generation of new astrocytes immediately adjacent to stroke in recovery remains to be defined. 
 
Neurogenesis and gliogenesis involve elemental cellular programs of tropism, migration and 
stimulation (neurogenesis) or inhibition (gliogenesis) by inflammation. However, these elemental 
cellular responses occur within the larger context of multi-cellular niches. Post-stroke 
neurogenesis occurs within a neurovascular niche in which angiogenesis and neurogenesis are 
causally inter-connected6-8. Gliogenesis occurs in a zone of reactive astrocytes and damaged 
axons and in both rodents and humans and appears limited by cues from these cellular 
compartments82,89. The emergent property of tissue regeneration after stroke is that neural 
progenitor responses occur in regenerative cellular niches within damaged tissues that are 
transient and unique to the injured brain. The concept of a progenitor niche in neural repair after 
stroke is informed by the concept of the stem cell niche. The original description of the stem cell 
niche explained the maintenance of bone marrow stem cells in aging and in response to 
chemotherapy90.  Scadden recently updated this concept: “Stem-cell populations are 
established in 'niches' — specific anatomic locations that regulate how they participate in tissue 
generation, maintenance and repairMIt constitutes a basic unit of tissue physiology, integrating 
signals that mediate the balanced response of stem cells to the needs of organisms.”91. 
Progenitor cells in stroke engage in tissue repair within transitory regenerative niches whose 
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properties  are emergent from the constituent cells and which induce the initial progenitor 
response, mediate cues from the surrounding environment, communicate signals that reflect 
age and likely co-morbid diseases, and ultimately define the outcome of recovery.  A promising 
area of future research will be to define the molecular signaling systems within these niches to 
enhance progenitor responses, maturation and repair. 
 
 
Engaging CNS Tissue Regeneration is like Activating a Cancer 
Neural repair means in part activating a growth program in an adult neuron to form new 
connections or inducing progenitor responses to tissue injury signals11-13,28. In axonal sprouting, 
induction of oncogenes such as c-myc92 and RAS93 promote the formation of new connections 
in stroke and spinal cord injury models. Blockade or inactivation of tumor suppressor proteins, 
such as PTEN and SOCS3, also promote axonal sprouting or functional recovery in stroke, 
spinal cord injury, optic nerve injury and other types of CNS injury 94,95 (ding et al). But PTEN is 
also mutated or inactivated in up to 70% of prostate cancers96,97 and 40% of glioblastomas98. 
SOCS3 is a tumor suppressor, and its function is lost in liver, lung, and squamous head and 
neck cancer99. Molecular receptor systems, such as TGFβ receptors, induce a growth state and 
axonal sprouting in stroke13 and also are key molecules in metastatic transformation in cancer, 
such as the epithelial-mesenchymal transition98,100,101. Recently described microRNA’s that 
induce neural repair or axonal growth responses, such as miR-9 and miR-133102,103 are also 
closely linked to oncogenesis104-106. Thus there is a substantial molecular overlap between gene 
systems that promote tissue regeneration and recovery in brain and spinal cord injury, including 
stroke, and also induce initial formation of a cancerous state or promote tumor metastasis. 
 
On a phenotypic level, there is similarity between neuronal and glial progenitor responses after 
stroke and cancer. Following a stroke, progenitor cells are induced into a growth program that 
involves cell division, migration to a tropic cue and association with angiogenic vessels6-8. This 
is a similar cellular response as tumor metastasis, in which primary tumor cells invade adjacent 
tissue, circulate and localize to angiogenic vessels98,100. Like metastatic tumor cells101, migrating 
progenitors after stroke secrete matrix metallproteinases to digest their way to the target 
tissue107.  Thus, neurogenesis after stroke occurs in a neurovascular niche and tumor 
metastases home to and then create a similar vascular niche.  
 
Each of the elemental properties of neural repair in stroke in neurogenesis and axonal 
sprouting, and in cancer in tumor initiation and metastasis, when taken into the larger context of 
biological responses in the body leads to this emergent property in CNS regeneration: molecular 
programs in cancer and in brain repair are shared. Outside of the CNS, similar pathways 
regulate tissue regeneration in other organ systems within molecular pathways that are also 
involved in cancer development108. This emergent property of tissue regeneration is obviously 
problematic for the design of neural repair therapies. The emergent property of neural repair as 
a cancer program leads to the next emergent property of neural repair. 
 
 
Neural Repair Therapies Require Directed Effect 
Therapies that stimulate neural repair after stroke will need to be controlled in their effect in both 
time and space because of the overlap in molecular programs between oncogenesis and neural 
repair. Also, outside of this cancer overlap, many of the growth factors or cytokines that 
stimulate neural repair in pre-clinical models have widespread effects in other body tissues. 
Examples of these are erythropoietin, fibroblast growth factor and G-CSF. In pre-clinical studies 
these molecules stimulated axonal sprouting, neurogenesis and other aspects of neural repair. 
However, in clinical trials their off-CNS effect limited their use, with renal, hemodynamic, bone 
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marrow and thrombogenic complications108-110. In addition to these past examples, recent 
discoveries in the neural repair field further make this point. The TGFβ family member GDF10 
serves as a signal after stroke that activates a gene expression program in peri-infarct tissue, 
which produces axonal sprouting and motor recovery13. However, this molecule signals through 
TGFβRI and II, and this system also plays a role in tumor metastasis101. A GDF10 therapeutic 
would need to be delivered locally to peri-infarct tissue, or only for a brief period in the subacute 
phase after stroke when axonal sprouting is active, or both—so as to minimize a potential 
oncogenic or non-CNS complications. Similar therapeutic control has been proposed for PTEN 
inhibition111, which would be another pathway to enhance axonal sprouting and recovery.  One 
mechanism for spatial and temporal control of delivery of a neural repair drug is to use tissue 
bioengineering, with hydrogels that self-assemble in brain and locally release a small molecule 
or biologic to the peri-infarct tissue11,13,33,112.  
 
 
Regeneration Does not Recapitulate Development 
CNS tissue regeneration or repair has many similarities to neurodevelopment. In the cortex 
adjacent to the stroke core, neurons lose their peri-neuronal net, show altered intracortical 
inhibition and become growth factor dependent5,12,114,115. These are hallmarks of neurons in the 
critical period of neuronal development, when cortex is uniquely plastic to environmental 
alterations in physiology and structure116. In post-stroke neurogenesis, multi-potent neural stem 
cells give rise to immature neurons which migrate long distances and mature in small numbers 
into neurons with synaptic connections and long distance projections6-8. This of course 
resembles both pyramidal neuron development in cortex and inhibitory neuron development in 
the forebrain117. Such similarity in tissue repair in stroke to neurodevelopment has prompted 
suggestions that brain regeneration recapitulates development118. Similar comparisons to 
regeneration and development have been made in other systems, such as kidney, bone, liver 
and skin119-122. 
  
This metaphor of regeneration to development takes its impetus from a similarity in phenotype: 
axonal extension and synaptogenesis, peri-neuronal net condition, growth factor dependency, 
neuroblast migration. However, what is critical for the biology of regeneration and for a possible 
regeneration therapeutic is whether the underlying molecular profile of CNS regeneration 
recapitulates the molecular profile of neurodevelopment. Initial transcriptional profiling of 
neurons that form new connections after stroke, retinal ganglion cells that regenerate an injured 
axon in the optic nerve, or dorsal root ganglion cells that re-grow a connection after peripheral 
nerve injury suggested some overlap to genes that are active in the developing nervous system, 
but overall a distinct set of genes that is regulated in these injury responses11,123. However, 
direct comparison of the transcriptome of neurons exposed to a regenerating stimulus after 
stroke and the transcriptomes of neurons at several stages of neuronal development from many 
different labs clearly indicates that the molecular expression profile of regeneration is 
statistically and fairly dramatically distinct from the developmental transcriptome13. Thus, an 
emergent property of neural repair is that on a molecular level regeneration does not 
recapitulate development. This principle is seen in other systems. The molecular control of 
regeneration is distinct from that in development in muscle repair124. Indeed, even in highly 
regenerative animals, like the newt or salamander in which a whole limb develops after injury, 




Recent studies have identified 7 emergent properties in neural repair after stroke. Stroke is not 
a killer but a chronic and progressively disabling disease. During the limited recovery that 
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occurs after stroke, the brain activates growth programs in surviving neurons, which can form 
new connections in ways that are sensitive to behavioral activity or neurorehabilitative 
paradigms. These molecular programs are distinct to CNS regeneration or modified from their 
context and overall signaling partners from those in neurodevelopment. Tissue repair after 
stroke occurs within transient regenerative cellular niches that communicate cues to the 
regenerating cells which ultimately limit these events. The response of neurons to grow new 
connections or in neural progenitors to repair damaged tissue shares molecular features with 
malignant transformation of tissues and with metastasis. These emergent properties of neural 
repair present opportunities for future therapeutic development and offer challenges in the 
delivery of such therapies (Figure). The field of neural repair has passed its first phase: the 
phenomenology of neural repair has been defined. Like walking down a summer path, the next 
steps in the field of neural repair are to appreciate the sounds of the cicadas, and more 
completely define how these individual neural repair phenomena interact, their emergent 
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